Buprenorphine Market Statistics, Global Analysis, Demand, Revenue and Trend Analysis Research Report by 2020 - 2027
Buprenorphine is a type of opioid that is used to treat opioid addiction, acute pain, and chronic pain. It can be injected (intravenous and subcutaneous), used as a skin patch (transdermal), or implanted under the tongue (sublingual), in the cheek (buccal), by injection (intravenous and subcutaneous), as a skin patch (transdermal), or as an implant. It is usually started when withdrawal symptoms start and for the first two days of treatment under the direct supervision of a health-care practitioner for opioid use disorder. To deter injectable usage, the combined formulation of buprenorphine/naloxone (Suboxone) is commonly recommended in the United States. In most cases, maximum pain relief occurs within an hour, with effects lasting up to 24 hours. Buprenorphine has various effects on different types of opioid receptors.
The rising number of opioid-addicted individuals is one of the primary factors driving buprenorphine market growth. The increased use of buprenorphine for the treatment of acute and chronic pain is predicted to fuel the Buprenorphine Market's expansion. The buprenorphine industry is likely to develop further as the FDA approves more buprenorphine medications for therapeutic use. In the near future, intensive research and development initiatives to broaden the therapeutic applications of buprenorphine medications are expected to assist the buprenorphine market's growth. The presence of a large number of buprenorphine producers is helping the buprenorphine market's growth. However, there are various side effects linked with buprenorphine, such as dizziness and memory loss, which limit the buprenorphine market's expansion.
Market Segmentation:
By Application
- Analgesic
- Opioid Antagonist
By Route of Administration
- Injectables
- Sublingual
- Transdermal Patches
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The major players operating in the global buprenorphine market are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichem Laboratories, Arevipharma GmbH, Resonance-labs, Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and Faran Shimi Pharmaceutical Co.
Comments
Post a Comment